Literature DB >> 31486276

Cardiovascular outcomes trials in type 2 diabetes: Time to include young adults.

Calvin Ke1,2,3, Baiju R Shah1,2,4, Andrea O Luk3,5, Erica Di Ruggiero6, Juliana C N Chan3,5,7.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31486276     DOI： 10.1111/dom.13874

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  4 in total

Review 1.  Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations.

Authors:  Calvin Ke; K M Venkat Narayan; Juliana C N Chan; Prabhat Jha; Baiju R Shah
Journal:  Nat Rev Endocrinol       Date:  2022-05-04       Impact factor: 47.564

2.  Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study.

Authors:  Calvin Ke; Thérèse A Stukel; Baiju R Shah; Eric Lau; Ronald C Ma; Wing-Yee So; Alice P Kong; Elaine Chow; Juliana C N Chan; Andrea Luk
Journal:  PLoS Med       Date:  2020-09-18       Impact factor: 11.069

Review 3.  Developing services to support the delivery of care to people with early-onset type 2 diabetes.

Authors:  Shivani Misra; David Gable; Kamlesh Khunti; Emma Barron; Bob Young; Partha Kar; Jonathan Valabhji
Journal:  Diabet Med       Date:  2022-08-23       Impact factor: 4.213

4.  Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trials.

Authors:  Jack A Sargeant; Emer M Brady; Francesco Zaccardi; Frances Tippins; David R Webb; Vanita R Aroda; Edward W Gregg; Kamlesh Khunti; Melanie J Davies
Journal:  Diabetologia       Date:  2020-06-02       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.